Blocking Potential Brain Metastases at the Blood Brain Barrier
This article was originally published in Start Up
The flip side of facilitating drug delivery through the blood brain barrier is to figure out how bad actors such as tumor cells sometimes ease through it. A research team recently identified an enzyme that helps breast cancer cells do just that. Blocking its activity could help prevent metastasis to the brain, which occurs in some 15% of breast cancer patients.
You may also be interested in...
A better understanding of heme trafficking could lead to drug targets in metabolic diseases, anemias, porphyrias, hemolytic diseases such as sickle cell disease – even parasitic infections.
A series of basic research insights around the cell death process called ferroptosis could form the underpinnings of a new class of treatments aimed at drug resistant tumors.
Recent clinical data using antisense drugs in neurological diseases are encouraging signs that targeting genetic drivers of ALS with antisense oligonucleotides or other gene-altering drugs could halt progression of several forms of the disease.